In Rare Move, CMS Cites FDA Warning Letter In National Coverage Request
This article was originally published in The Gray Sheet
Executive Summary
CMS' internally-generated national coverage request for infrared therapy devices uncharacteristically refers to a recent FDA warning letter to manufacturer Anodyne Therapy